OtherBasic Science (Animal or Phantoms)
A dual-modality linker enables site-specific conjugation of antibody fragments for 18F-immunoPET and fluorescence imaging
Kirstin A Zettlitz, Christopher M Waldmann, Wen-Ting K Tsai, Richard Tavaré, Jeffrey Collins, Jennifer M Murphy and Anna M. Wu
Journal of Nuclear Medicine March 2019, jnumed.118.223560; DOI: https://doi.org/10.2967/jnumed.118.223560
Kirstin A Zettlitz
1 Beckman Research Institute City of Hope, United States;
Christopher M Waldmann
2 University Medical Center Mainz, Germany;
Wen-Ting K Tsai
3 University of California Los Angeles, United States;
Richard Tavaré
4 Regeneron Pharmaceuticals Inc, United States;
Jeffrey Collins
3 University of California Los Angeles, United States;
Jennifer M Murphy
3 University of California Los Angeles, United States;
Anna M. Wu
5 Beckman Research Institute of the City of Hope, United States
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
A dual-modality linker enables site-specific conjugation of antibody fragments for 18F-immunoPET and fluorescence imaging
Kirstin A Zettlitz, Christopher M Waldmann, Wen-Ting K Tsai, Richard Tavaré, Jeffrey Collins, Jennifer M Murphy, Anna M. Wu
Journal of Nuclear Medicine Mar 2019, jnumed.118.223560; DOI: 10.2967/jnumed.118.223560
A dual-modality linker enables site-specific conjugation of antibody fragments for 18F-immunoPET and fluorescence imaging
Kirstin A Zettlitz, Christopher M Waldmann, Wen-Ting K Tsai, Richard Tavaré, Jeffrey Collins, Jennifer M Murphy, Anna M. Wu
Journal of Nuclear Medicine Mar 2019, jnumed.118.223560; DOI: 10.2967/jnumed.118.223560
Jump to section
Related Articles
Cited By...
- No citing articles found.